| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 5 | |
| #2 | United States | 4 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | Australia | 2 | |
| #5 | China | 2 | |
| #6 | Canada | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology | |
| #4 | Foods and drinks |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Climate change adaptation technologies | |
| #5 | Enzymes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Agrawal Babita | 17 |
| #2 | Kumar Rakesh | 15 |
| #3 | Gupta Nancy | 5 |
| #4 | Singh Shakti | 3 |
| #5 | Longenecker Bryan Michael | 1 |
| #6 | Parker Joanne | 1 |
| #7 | Longenecker Michael B | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AU2016311387A1 | Immunomodulatory compositions and methods of use thereof | |
| WO2016112459A1 | Methods of inducing an immune response to hepatitis c virus | |
| AU2015205342A1 | Immunomodulatory compositions and methods of use thereof | |
| WO0170265A2 | Lipopeptide adjuvants | |
| WO0061766A2 | Telomerase-specific cancer vaccine |